The Companies and Markets show: Haleon listing, the business of psychedelics, and a European gas crisis
Investors' Chronicle · Investors' Chronicle
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
On this week's show, we get the breakdown on GSK spinoff Haleon which is set to list next week.
Then Arthur Sants takes a fascinating dive into the business of psychedelic drugs, and whether they can be the future of depression and anxiety treatment.
Finally, the panel look into the potential European gas crisis, with the threat of Russian pipelines being turned off hanging over the continent.
Dan Jones host Alex Newman, Alex Hamer, Mark Robinson and Arthur Sants.
Timestamps:
00:00 - Intro
01:00 - News roundup
02:49 - GSK spinoff Haleon listing previewed
13:24 - Can psychedelics be the future of anxiety treatment?
23:16 - A looming European gas crisis?
Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.
Investors' Chronicle is a service by the Financial Times.
Hosted on Acast. See acast.com/privacy for more information.